Skip NavigationSkip to Content

Induction of stem cell factor/c-Kit/Slug signal transduction in multidrug-resistant malignant mesothelioma cells

  1. Author:
    Catalano, A.
    Rodilossi, S.
    Rippo, M. R.
    Caprari, P.
    Procopio, A.
  2. Author Address

    Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, I-60131 Ancona, Italy. Italian Natl Res Ctr Aging, Lab Cytol, I-60124 Ancona, Italy. NCI, Neural Dev Grp, Mouse Canc Genet Program, NIH, Frederick, MD 21701 USA Catalano, A, Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Via Ranieri, I-60131 Ancona, Italy
    1. Year: 2004
    2. Date: NOV 5
  1. Journal: Journal of Biological Chemistry
    1. 279
    2. 45
    3. Pages: 46706-46714
  2. Type of Article: Article
  1. Abstract:

    Malignant mesothelioma (MM) is strongly resistant to conventional chemotherapy by unclear mechanisms. We and others have previously reported that cytokine- and growth factor-mediated signal transduction is involved in the growth and progression of MM. Here, we identified a pathway that involves stem cell factor (SCF)/c-Kit/Slug in mediating multidrug resistance of MM cells. When we compared gene expression profiles between five MM cells and their multidrug-resistant (MM DX) sublines, we found that MM DX cells expressed both SCF and c-Kit and had higher mRNA levels of Slug. Knockdown of c-Kit or Slug expression with their respective small interfering RNA sensitized MM DX cells to the induction of apoptosis by different chemotherapeutic agents, including doxorubicin, paclitaxel, and vincristine. Transfection of c-Kit in parental MM cells in the presence of SCF up-regulated Slug and increased resistance to the chemotherapeutic agents. Moreover, MM cells expressing Slug showed a similar increased resistance to the chemotherapeutic agents. These results indicate that induction of Slug by autocrine production of SCF and c-Kit activation plays a key role in conferring a broad spectrum chemoresistance on MM cells and reveal a novel signal transduction pathway for pharmacological or genetic intervention of MM patients

    See More

External Sources

  1. WOS: 000224832400048

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel